Ivacaftor synthesis of Ivacaftor Ivacaftor Intermediate CAS No 1246213-45-5 IUPAC Name Carbonic acid 5-[[(1,4-dihydro-4-oxo-3-quinolinyl)carbonyl]amino]-2,4-bis(1,1-dimethyl ethyl)phenylmethyl ester Synonyms Ivacaftor Methylcarbonate Molecular Formula C26H30N2O5 Molecular Weight 450.53

Regorafenib synthesis of Regorafenib Afatinib Intermediate CAS No 757251-39-1 IUPAC Name 4-(4-Amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide Synonyms Regorafenib Amine Molecular Formula C₁₃H₁₂FN₃O₂ Molecular Weight 261.25

Afatinib Afatinib is a medication used to treat a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has specific genetic mutations. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) and works by blocking proteins involved in the growth of cancer cells. Afatinib is specifically used for NSCLC…

Sorafenib Sorafenib is an innovative targeted therapy used in the treatment of advanced cancers, particularly renal cell carcinoma, and hepatocellular carcinoma. By inhibiting multiple kinases involved in tumor growth and angiogenesis, Sorafenib disrupts cancer cell proliferation and hampers the formation of blood vessels that nourish tumors. Its anti-tumor and anti-angiogenic effects have shown promising results…